Drug Profile
Sarsasapogenin- Phytopharm
Alternative Names: Cogane; JNX-1001; PYM-50028; SmilageninLatest Information Update: 16 Apr 2021
Price :
$50
*
At a glance
- Originator Phytopharm
- Developer IXICO
- Class Antidementias; Herbal medicines; Neuroprotectants; Nootropics; Small molecules; Steroid sapogenins
- Mechanism of Action Brain derived neurotrophic factor agonists; Glial cell line-derived neurotrophic factor agonists; Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Amyotrophic lateral sclerosis; Glaucoma; Parkinson's disease
Most Recent Events
- 16 Apr 2021 Discontinued - Phase-II for Alzheimer's disease in United Kingdom (PO)
- 16 Apr 2021 Discontinued - Phase-II for Parkinson's disease (Early-stage disease) in United Kingdom, Serbia, Poland, Romania, Hungary, Germany, France, Czech Republic, Canada, USA (PO)
- 16 Apr 2021 Discontinued - Preclinical for Amyotrophic lateral sclerosis in United Kingdom (PO)